FLZ-37555-33630
4 vaccinations
3 coded responses
22 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 600 / IL
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-22
Dose 1 — Pfizer-BioNTech
-
2021-04-23
Registered in v-safe
-
2021-04-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-28
- 2021-04-29
- 2021-05-06
- 2021-05-13
-
2021-05-14
Dose 2 — Pfizer-BioNTech
- 2021-05-20
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-19
- 2021-06-25
-
2021-08-13
Survey response — 3 months, dose 2MedDRA: Fall, Limb injury, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Slip and fall on wet floor, shoulder injury, muscular pain, poosible partial tendon tear or bursitis. Unrelated to Covid or the vaccine.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-14
-
2021-12-08
Dose 3 — Pfizer-BioNTech
-
2022-05-14
Survey response — 12 months, dose 2MedDRA: Illness, Impaired work ability, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Common cold; 1st illness of any kind since before pandemic. Stayed home from work for 1 day, 2 negative Covid home tests 2 days apart.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Dose 4 — Pfizer-BioNTech
-
2022-10-11
Survey response — day 14, dose 4MedDRA: Body temperature increased, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend schoolFree text: Sore throat, head congestion, & mild fever (below 100) beginning on Oct 7, 2022, immediate strong positive on 2 Covid Rapid Tests on Oct 8, 2022. Continuing head congestion to varying degrees since then. Blood-oxygen has not dropped below 95%MedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-12-23
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-22 | Pfizer-BioNTech | |
| 2 | 2021-05-14 | Pfizer-BioNTech | |
| 3 | 2021-12-08 | Pfizer-BioNTech | No |
| 4 | 2022-09-23 | Pfizer-BioNTech | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: Slip and fall on wet floor, shoulder injury, muscular pain, poosible partial tendon tear or bursitis. Unrelated to Covid or the vaccine.
Release 11 — 12 months, dose 2
Symptoms: Common cold; 1st illness of any kind since before pandemic. Stayed home from work for 1 day, 2 negative Covid home tests 2 days apart.
Release 12 — day 14, dose 4
Symptoms: Sore throat, head congestion, & mild fever (below 100) beginning on Oct 7, 2022, immediate strong positive on 2 Covid Rapid Tests on Oct 8, 2022. Continuing head congestion to varying degrees since then. Blood-oxygen has not dropped below 95%
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Fall | ✓ | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Limb injury | ✓ | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release